⌘K

Login Start Free

Home/Filings/4/0001104659-22-073095

4//SEC Filing

Lefenfeld Michael 4

Accession 0001104659-22-073095

CIK 0001472012other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:02 PM ET

Size

5.2 KB

Accession

0001104659-22-073095

Insider Transaction Report

Form 4

Period: 2022-06-16

Immunome Inc.IMNM

Lefenfeld Michael

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-16+6,500→ 6,500 total
Exercise: $2.62Exp: 2032-06-16→ Common Stock (6,500 underlying)

Footnotes (1)

[F1]The shares subject to the options shall vest 25% every quarter after the grant date.

Documents

1 file

4
tm2218674-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001826906

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 6:02 PM ET
Size: 5.2 KB

View on SEC.gov